Research Article
Synthesis and In Vitro and In Vivo Evaluation of a New 68Ga-Semicarbazone Complex: Potential PET Radiopharmaceutical for Tumor Imaging
Table 1
Biodistribution of 68Ga-(2-acetylpyridine semicarbazone)2 complex (68Ga-[APSC]2) in tumor bearing nude mice.
| | 1 h | 2 h | 4 h | 24 h* |
| Blood | 17.71 ± 1.33 | 6.41 ± 0.10 | 3.45 ± 0.57 | 2.13 ± 0.08 | Liver | 7.04 ± 0.06 | 4.14 ± 0.31 | 3.51 ± 0.09 | 2.13 ± 0.53 | Lung | 7.34 ± 0.37 | 4.03 ± 0.27 | 3.61 ± 0.72 | 1.87 ± 0.20 | Kidney | 6.18 ± 0.94 | 4.81 ± 0.47 | 3.25 ± 0.21 | 6.15 ± 0.72 | Intestine | 5.21 ± 0.44 | 8.22 ± 0.02 | 3.80 ± 0.89 | 3.76 ± 0.68 | Heart | 5.75 ± 0.92 | 2.31 ± 0.55 | 2.16 ± 0.27 | 1.07 ± 0.08 | Muscle | 2.33 ± 0.33 | 1.54 ± 0.49 | 0.75 ± 0.11 | 0.37 ± 0.08 | Spleen | 4.76 ± 0.43 | 5.01 ± 0.80 | 3.88 ± 0.24 | 2.88 ± 0.26 | Tumor | 3.52 ± 0.59 | 11.58 ± 1.07 | 4.08 ± 0.04 | 2.22 ± 0.01 |
|
|
The values are average of % injected dose/gram ± SD for . Animals were injected with 67Ga-[APSC]2 radiotracer.
|